BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 392416)

  • 21. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
    Sezer O; Heider U; Zavrski I; Possinger K
    Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Contribution of bone biopsy with histomorphometry in the evaluation of monoclonal gammopathy].
    Alexandre C; Bataille R; Chappard D; Dessauw P; Sany J; Riffat G
    Rev Rhum Mal Osteoartic; 1987 Nov; 54(11):717-21. PubMed ID: 3423714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation of benign monoclonal gammopathy and smouldering multiple myeloma from frank myeloma.
    Shimizu K; Ohnishi K; Kunii A
    Clin Exp Immunol; 1982 Dec; 50(3):596-600. PubMed ID: 6819908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cytochemical demonstration of beta-glucuronidase and beta-acetylglucosaminidase in plasmacytoma].
    Löffler H; Platt D; Platt M
    Klin Wochenschr; 1970 Apr; 48(8):480-2. PubMed ID: 5519401
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cytochemistry of plasma cells (author's transl)].
    Miliani A; Anichini P; Pellegrini G; Firorelli C; Cozzolino F
    Haematologica; 1979 Oct; 64 Suppl():35-9. PubMed ID: 161540
    [No Abstract]   [Full Text] [Related]  

  • 26. Detection of monoclonal gammapathies by the presence of certain peculiar changes on the Giemsa-stained blood smear.
    Gingold N
    Med Interne; 1980; 18(1):69-73. PubMed ID: 6154963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rheumatoid factors and clinical relations in monoclonal gammapathies. Analysis of a sample of 583 individuals (author's transl)].
    Hrncír Z; Tichý M
    Cas Lek Cesk; 1979 Aug; 118(35):1088-92. PubMed ID: 519677
    [No Abstract]   [Full Text] [Related]  

  • 28. [Monoclonal gammopathies: classical parameters and beta 2 microglobulins in the differential diagnosis].
    Ortega F; San Miguel JF
    Sangre (Barc); 1984; 29(5):895-906. PubMed ID: 6441292
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies.
    Lima M; Teixeira Mdos A; Fonseca S; Gonçalves C; Guerra M; Queirós ML; Santos AH; Coutinho A; Pinho L; Marques L; Cunha M; Ribeiro P; Xavier L; Vieira H; Pinto P; Justiça B
    Blood Cells Mol Dis; 2000 Dec; 26(6):634-45. PubMed ID: 11358356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multiple myeloma and idiopathic monoclonal gammapathy. Diagnosis, prognosis and treatment].
    Bladé J
    Med Clin (Barc); 1988 Apr; 90(17):704-14. PubMed ID: 3045448
    [No Abstract]   [Full Text] [Related]  

  • 31. [Myeloma and "related" gammapathies].
    Val'denstrem Ia
    Probl Gematol Pereliv Krovi; 1974 Aug; 19(8):14-8. PubMed ID: 4212715
    [No Abstract]   [Full Text] [Related]  

  • 32. N-acetyl-beta-glucosaminidase, beta-glucuronidase and beta-galactosidase in the leukocytes, serum and urine of healthy subjects and patients with immunocytoma.
    Kraj M; Cieśluk S; Czartoryska B; Górska D; Mdzewski B; Sawicki Z
    Arch Immunol Ther Exp (Warsz); 1980; 28(3):503-14. PubMed ID: 6778453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic factors and markers of activity in multiple myeloma (results of the Cooperative Group for Diagnosis and Treatment of Multiple Myeloma)].
    Spicka I; Cieslar P; Procházka B; Jirsa M; Chrz M; Gregora E; Klener P
    Cas Lek Cesk; 2000 Apr; 139(7):208-12. PubMed ID: 10916207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Monoclonal myelomatous and non-myelomatous immunoglobulinemia: a contribution to differential diagnosis].
    Romano L; Argenziano A; D'Agostino F; Cantatore D; Olivieri D
    Arch Monaldi; 1979; 34(3):132-7. PubMed ID: 555640
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma cell leukemia and monoclonal (IgG) gammopathy in a dog.
    Couto CG; Ruehl W; Muir S
    J Am Vet Med Assoc; 1984 Jan; 184(1):90-2. PubMed ID: 6698844
    [No Abstract]   [Full Text] [Related]  

  • 36. Asymptomatic (benign) monoclonal gammopathy--a study of 100 patients.
    Pick AI; Shoenfeld Y; Skvaril F; Schreibman S; Fröhlichman R; Weiss H; Pinkhas J
    Ann Clin Lab Sci; 1977; 7(4):335-43. PubMed ID: 409332
    [No Abstract]   [Full Text] [Related]  

  • 37. Scoring system for cytochemical betaglucuronidase activity in normal bone marrow plasmacells and myelomacells.
    Van der Planken M; Berneman Z; Peetermans M
    Acta Clin Belg; 1982; 37(2):80-3. PubMed ID: 7113573
    [No Abstract]   [Full Text] [Related]  

  • 38. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
    Lauta VM
    Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic criteria of multiple myeloma.
    Kyle RA
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correlation between beta-glucuronidase activity and serotype in the genus "Salmonella" (author's transl)].
    Le Minor L; Buissière J; Novel G; Novel M
    Ann Microbiol (Paris); 1978; 129B(2):155-65. PubMed ID: 363016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.